FDA Adverse Event Malfunction Summary report: N

CEFOTAXIME CTL 32 US S30

MDR report key: 5083567 · Received September 17, 2015

Report

Report Number
3002769706-2015-00087
Event Type
Malfunction
Date Received
September 17, 2015
Report Date
July 21, 2015
Manufacturer
BIOMERIEUX SA
Product Code
JWY
PMA / PMN Number
K981137
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MD, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

DEVICE NOT RETURNED TO MANUFACTURER.

Additional Manufacturer Narrative · 1

THIS REPORT WAS INITIALLY SUBMITTED FOLLOWING NOTIFICATION THAT A CUSTOMER IN THE UNITED STATES REPORTED PSEUDOMONAS AERUGINOSA ATCC® 27853 TM OUT-OF-RANGE-HIGH (MIC >=32) IN ASSOCIATION WITH ETEST® CEFOTAXIME CTL 32. INTERNAL INVESTIGATION WAS CONDUCTED. ETEST® CEFOTAXIME CTL 32 IS ONLY RECOMMENDED FOR STREPTOCOCCUS AND FASTIDIOUS STRAINS. ETEST® CEFOTAXIME CTL 32 IS NOT ADAPTED FOR PSEUDOMONAS AERUGINOSA. THIS IS WHY PSEUDOMONAS AERUGINOSA ATCC® 27853 TM IS NOT RECOMMENDED FOR QUALITY CONTROL TESTING AGAINST THIS PRODUCT. INSTRUCTIONS FOR USE SUPPLEMENTARY INSERT US 15221 STATES TO "PLEASE CONSULT THE FOOTNOTES IN THE LATEST CLSI TABLES FOR FURTHER COMMENTS AND CLARIFICATION. INTERPRETIVE CRITERIA MAY BE DIFFERENT." IN CLSI, THERE ARE NO BREAK POINTS FOR PSEUDOMONAS AERUGINOSA. THE ETEST® CEFOTAXIME CTL 32 PRODUCT IS PERFORMING IN ACCORDANCE TO PERFORMANCE CLAIMS.

Description of Event or Problem · 1

A CUSTOMER CALLED WITH OUT OF RANGE RESULTS FOR QC TESTING USING ETEST CEFOTAXIME CTL 32 US S30, (B)(4), LOT 1004047910. QUALITY CONTROL TESTING FOR PSEUDOMONAS AERUGINOSA 27853 WERE OUT OF RANGE (HIGH) AND E. COLI 25922 WAS ACCEPTABLE. ADDITIONAL SET-UP AND TESTING PERFORMED WITH THE SAME RESULTS. PRODUCT FROM A DIFFERENT LOT ARE BEING SENT TO THE CUSTOMER FOR USE. AN INTERNAL INVESTIGATION HAS BEEN LAUNCHED. THERE WAS NO REPORTED DEATH OR SERIOUS INJURY ASSOCIATED WITH THE REFERENCED EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
614739 CEFOTAXIME CTL 32 US S30 CEFOTAXIME CTL 32 US S30 JWY BIOMERIEUX SA 1004047910

Patients

Seq Age Sex Outcome Treatment
1